Hatteras Venture Partners related stories
All articles and analysis
Week in deals, Jan. 18. 2010Summary of North American tech companies and other startups that raised venture financing in the past week
- Week in deals, Jan. 11, 2010
Summary of North American tech companies and other startups that raised venture financing in the past week
- Phase Bioscience Raises $25 Million
Phase Bioscience Inc., a Durham, N.C.-based developer of therapeutic fusion proteins, has raised$25 million in new Series B funding. New Enterprise Associates and a unit of OSI Pharmaceuticals were joined by return backers Hatteras Venture Partners, Johnson & Johnson Development Corp. and Fletcher Spaght Ventures. The company previously raised around $6.8 million.
- peHUB Wire: Friday, January 8, 2010
Friday Feedback
- peHUB Wire: Friday, January 8, 2010
Friday Feedback
- HistoSonics Raises $11 Million
HistoSonics, an Ann Arbor, Mich.-based developer of an image-guided system that ablates tissue, has raised $11 million in Series A funding. Venture Investors led the round, and was joined by Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.
- Embrella Cardiovascular Adds $1.6 Million
Embrella Cardiovascular, a Malvern, Penn.-based developer of a device for preventing dangerous debris from entering the brain during cardiovascular procedures, has raised $1.6 million in new Series B funding, bringing the round total to $6.7 million. BioStar Ventures and return backer MedFocus Fund co-led the round, with Edwards Lifesciences Corp. also participating.
- Week in deals, July 13, 2009
Summary of tech companies and other businesses that raised financing in the past week